msemporda.blogspot.com
msemporda: The Science and Ethics of Genetically Engineered Human DNA - Congressional Hearing
http://msemporda.blogspot.com/2015/06/the-science-and-ethics-of-genetically.html
The Science and Ethics of Genetically Engineered Human DNA - Congressional Hearing. Backstory and current state-of-play review in a formal setting w/ Q&A -. Via Paul Knoepfler's Blog post: ". Doudna and Others Testify Before Congress on CRISPR, Human Germline Editing. Subscribe to: Post Comments (Atom). Most Recent Blog Posts In:. Featured Coverage - ISSCR. Stem Cells and The Aging Brain - Karolinska Symposium. Biotech Spin-Outs: Discovery Company. Media Hype ESi Bio CIRM's Chairman. Pluripotent Stem Cel...
msemporda.blogspot.com
msemporda: The Hemangioblast Progeny - Ocata's Blood, Immune & Cancer Programs
http://msemporda.blogspot.com/2015/01/the-hemangioblast-prodigy-ocatas-blood.html
The Hemangioblast Progeny - Ocata's Blood, Immune and Cancer Programs. When we speak of the various programs Ocata has in development, apart from the Eye, they are referred to as "other" and are separated into boxes so the general targets become clearer - Blood, Immune and Cancer. However, it important to understand that all these "others," and their various derivative relations, are based off of the Hemangioblast cell state precursor. i.e. e. Immune Modulation using MSCs, e. A program for engineered eDe...
msemporda.blogspot.com
msemporda: ISSCR 2015 Annual Meeting Coverage
http://msemporda.blogspot.com/2015/07/isscr-2015-annual-meeting-coverage.html
ISSCR 2015 Annual Meeting Coverage. I recently attended the annual meeting of the. International Society for Stem Cell Research. And have been writing up the coverage in dedicated articles which you will find the links to below and also to the right. The interview with Dr. Sally Temple entitled ". Cells, Leadership and Audacious Innovation". Can be found here. I wish to thank the ISSCR for the opportunity and to Michelle Quivey, Snr Comms Mgr, for her professional handling of the media scheduling. Michae...
msemporda.blogspot.com
msemporda: OCATA Eye
http://msemporda.blogspot.com/p/ocata-eye.html
Ocata's hESC RPE Cell Therapeutic Candidate Review. HESC-MA09 RPE (no trade name yet). Formerly Advanced Cell Technology Inc.). Human allogeneic embryonic stem cell-derived retinal pigment epithelium (RPE), expanded. Blastomere cell derived from fertilized oocytes. Pre-embryo consent use provided as supernumerary tissue for cell extraction for science rather than discarding during standard IVF treatment. Patented non-embryo destructive technology (NED) used to establish hESC cell line –. Human embryonic ...
msemporda.blogspot.com
msemporda: UC London
http://msemporda.blogspot.com/p/univ-coll-london.html
In the following review University College London's Eye Therapy department outlines. Its activities in their Gene and Cell Therapy Programs. In addition to the below you can also link to review details on The London Project to Cure Blindness. By Pete Coffey of UCL in partnership with Pfizer. This project uses RPE cells on a "membrane" sheet in advanced Wet AMD, similar to Riken's iPS RPE project. Each year, a number of organisations mark this day with a focus on improving understanding and communication ...
msemporda.blogspot.com
msemporda: Germline Science & Embryo Use - The Law & Scope for Applied Research
http://msemporda.blogspot.com/2015/05/germline-science-embryo-use-law-scope.html
Germline Science and Embryo Use - The Law and Scope for Applied Research. NIH statement on editing human embryo DNA. Recent reiteration by the Director. Of the NIH, Dr. Francis Collins, that the long held legal position of the US Federal Government is to. Not fund destructive embryo research. Brings the US debate on germ line editing front and center in practical terms. Use" of human embryos, for their own benefit, is written into the established. However, apart from the embryo "use" issue, the. In all i...
msemporda.blogspot.com
msemporda: OCATA Immune/Cancer
http://msemporda.blogspot.com/p/ocata-immune.html
When we speak of the various programs Ocata has in development, apart from the Eye, they are referred to as "other" and are separated into boxes so the general targets become clearer - Blood, Immune and Cancer. However, it important to understand that all these "others," and their various derivative relations, are based off of the Hemangioblast cell state precursor. i.e. e. Immune Modulation using MSCs, e. Cancer Targeting using Dendritic/NK cells & e. A program for engineered eDendritic cells targeting ...
msemporda.blogspot.com
msemporda: RIKEN
http://msemporda.blogspot.com/p/rik-ip.html
RIKEN to resume retinal iPS transplant. KOBE (Jiji Press) — The government-affiliated research institute RIKEN said Monday that it will resume its clinical study in which retinal tissues developed from iPS cells will be transplanted in an eye disease patient, in cooperation with Kyoto University and other medical institutes. In the first trial, iPS cells were created from cells taken from the patient who underwent the transplant. The four institutes have signed an agreement to strengthen their collaborat...
msemporda.blogspot.com
msemporda: Cancer
http://msemporda.blogspot.com/p/cancer.html
Dr June - Univ Penn. Early in 2013 I was researching the topic of Immunotherapy for a piece I was putting together for a creative non-fiction writing competition at Eurostemcell.org. Dr Grupp - CHOP. I wrote the below as the competition entry and later published it on iCell. Although I didn't get the nod by the panel at Eurostemcell it was a cathartic project for me and one which I can look back on as rewarding. The CAR-T and other modified Immune cell technologies are now gaining traction as a result of...
SOCIAL ENGAGEMENT